Key Achievements of T21
Since its inception in 2019, T21 has strived to create the largest body of evidence for the safety and efficacy of medical cannabis, providi
top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
James Bunn
Jul 312 min read
Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study
To document the prevalence and correlates of suicidal ideation (SI) among individuals seeking cannabis-based medicinal products (CBMPs); to
Michael Lynskey
Jun 172 min read
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well‑Being: Findings from T21
There are important differences between individuals aged 65+ years and younger individuals receiving cannabis-based medicinal products. Olde
Alkyoni Anthanasiou-Fragkouli
Jun 62 min read
Prescribed Medicinal Cannabis for the Treatment of Chronic Pain Comorbid with Depression: Real World Evidence from Project Twenty21
Chronic pain is one of the most common conditions for which people seek treatment with cannabis-based medicinal products (CBMPs) and there i
Dr Anne Schlag, Professor David Nutt and more
Mar 121 min read
Medicinal cannabis for treating PTSD and comorbid depression: Real World Evidence from Project T21
Authors Michael Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, Anne Schlag and David Nutt Published March 12, 2024 Background...
Drug Science
Dec 12, 20233 min read
UK’s largest medical cannabis study announces new industry partners
Launched in 2019, and now over 4000 patients in, T21 is building the scientific evidence base for the safety and efficacy of Cannabis-Based
Kylie O’Brien, Justin Beilby and more
May 25, 20232 min read
Medicinal cannabis for pain: Real-world data on three-month changes in symptoms and quality of life
Internationally, one of the most common conditions for which people seek medicinal cannabis (MC) is chronic pain. However, relatively little
Professor Michael Lynskey, Dr Anne Schlag and more
May 5, 20232 min read
Characteristics of and 3-month health outcomes for people seeking treatment with prescribed cannabis
Medicinal cannabis has been legal in the UK since 2018 but there is limited information about characteristics of people seeking prescribed
Kylie O’Brien, Justin Beilby and more
Mar 23, 20232 min read
Preliminary findings from T21 Australia
An observational study of patients prescribed medicinal Cannabis for chronic pain, anxiety, posttraumatic stress disorder and multiple...
Louise McConnell
Mar 20, 20232 min read
Combating the stigma: a T21 success story
By Louise McConnell Although medical cannabis has been legal in the UK for more than four years, there still exists a great deal of...
Drug Science
Feb 24, 20232 min read
Grow Pharma joins T21
Drug Science is pleased to welcome Grow Pharma as a partner on its groundbreaking medical cannabis study, T21. Launched in 2019, T21 is...
Drug Science
Feb 13, 20233 min read
Parents and scientists back new study into benefits of cannabis-based medications for children with severe epilepsy
Today, on International Epilepsy Day, patient group MedCan Support, scientific body Drug Science and tech-platform Alta Flora announce...
Drug Science
Jan 24, 20231 min read
Drug Science’s medical cannabis patient registry (T21) sees departure of Lyphe Group and introduces new pricing model
The subsidised pricing structure of Drug Science’s medical cannabis registry, ‘T21’, is changing to a new model. Until now, T21 has...
Drug Science
Jan 16, 20234 min read
Drug Science’s medical cannabis patient registry (T21) to continue for a fourth year
Today (16 January 2023) Drug Science announces that its medicinal cannabis patient registry ‘T21’ is continuing for a fourth year — and...
Drug Science
Feb 8, 20222 min read
Medical Cannabis study Project Twenty21 begins in Australia
7th February 2021 Drug Science’s large scale observational study of medical cannabis has opened its first non-UK operation in Australia...
Drug Science
Jan 6, 20224 min read
Project Twenty21 in 2022: A Message for Patients
Update What you have helped us achieve so far Our medical cannabis registry, Project Twenty21, was originally designed to run until the...
Drug Science
Sep 14, 20213 min read
Project Twenty21 - September Update
Get Project Twenty21 Updates via Email Last month saw Drug Science’s festival debut as we took up a stand alongside our medical cannabis...
Drug Science
Aug 10, 20214 min read
Project Twenty21 - August Update
Get Project Twenty21 Updates via Email It’s been another busy month at Project Twenty21, with new patient numbers continuing to grow...
Drug Science
Jul 13, 20214 min read
Project Twenty21 - July Update
In this update, find out what GPs think about medical cannabis as we celebrate 1000 patients joining Project Twenty21. We share updates...
Drug Science
Jun 9, 20213 min read
Project Twenty21 - June Update
In this update, we reveal a new clinical analysis of epilepsy T21 epilepsy patients and share the latest data and patient stories from...
Drug Science
Mar 12, 20213 min read
Project Twenty21 - March Update
In this update, we reveal the latest data and patient feedback from Project Twenty21, and answer some common questions from patients. We...
bottom of page